Primary histiocytic sarcoma of the spleen associated with hemophagocytosis

International Journal of Hematology

Volumn 87, Issue 4, 2008, Pages 405-409

  Oka, Koji ^a   Nakamine, Hirokazu ^b   Maeda, Kunihiko ^c   Yamakawa, Mitsunori ^c   Imai, Hiroshi ^d   Tada, Kohei ^a   Ito, Motohiro ^a   Watanabe, Yasuyuki ^a   Suzuki, Hikoji ^a   Iwasa, Makoto ^a   Tanaka, Isao ^a  

^a Suzuka Kaisei Hospital   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c YAMAGATA UNIVERSITY   (Japan)

^d MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hemophagocytosis; Histiocytic sarcoma; Spleen

Indexed keywords

BIOLOGICAL MARKER; CARBOPLATIN; CD163 ANTIGEN; CD68 ANTIGEN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; LYSOZYME; PREDNISOLONE; PROTEIN S 100; VINCRISTINE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; ARTIFICIAL EMBOLISM; CASE REPORT; CELL NUCLEUS; CELL VIABILITY; CORTICOSTEROID THERAPY; CYTOPLASM; DISEASE ASSOCIATION; DISEASE COURSE; DRUG MEGADOSE; ERYTHROCYTE; ERYTHROPHAGOCYTOSIS; FEMALE; HUMAN; HUMAN TISSUE; LEUKOCYTE; MACROPHAGE; MONOCYTE; NECROSIS; PREOPERATIVE EVALUATION; PRIMARY HISTIOCYTIC SARCOMA; PROTEIN EXPRESSION; SARCOMA; SPLEEN; SPLENECTOMY; SPLENOMEGALY; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

FEMALE; HUMANS; MIDDLE AGED; PHAGOCYTOSIS; SARCOMA; SPLENIC NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT FAILURE;

EID: 46149085150     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-008-0059-6     Document Type: Article

References (12)

1. Weiss LM, Grogan TM, Mueller-Hermelink H-K, et al. Histiocytic sarcoma. In: Jeffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organaization classification of tumors: pathology and genetics of tumors of haematopoietic and lymphoid tissues. Lyon, France: International Agency for Research on Cancer Press; 2001. pp. 278-9.
2. Pileri SA, Grogan TM, Harris NL, et al. Tumours of hisiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology. 2002;41:1-29.
3. Vos AJ, Abbondanzono SL, Barekman CL, Andriko JW, Miettien M, Aguilera NS. Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163. Mod Pathol. 2005;18:693-704.
4. Copie-Bergman C, Wotherspoon AC, Norton AJ, Diss TC, Isaacson PG. True histiocytic lymphoma: a morphologic immnohistochemical and molecular genetic study of 13 cases. Am J Surg Pathol. 1998;22:1386-92.
5. Hornick JL, Jaffe ES, Fletch CDM. Extranodal histiocytic sarcoma. Clinicopathologic analysis of 14 cases of a rare epithelioid malignancy. Am J Surg Pathol. 2004;28:1133-44.
6. Lauritzen AF, Delsol G, Hansen NE, et al. Histiocytic sarcoma and monoblastic leukemias: a clinical, histologic, and immunopheotypical study. Am J Clin Pathol. 1994;102:45-54.
7. Audouin J, Vercelli-Retta J, Le Touneau A, et al. Primary histiocytic sarcoma of the spleen associated with erythrophagocytic histiocytosis. Pathol Res Pract. 2003;199:107-12.
8. Franchino C, Reich C, Distenfeld A, et al. A clinicopathologically distinctive primary splenic histiocytic neoplasm: demonstration of its histiocytic derivation by immunophenotypic and molecular genetic analysis. Am J Surg Pathol. 1988;12:398-404.
9. Kimura H, Nasu K, Sakai C, et al. Histiocytic sarcoma of the spleen associated with hypoalbuminemia hypo γ-globulinemia and thrombocytopenia as a possibly unique clinical entity: report of three cases. Leuk Lymphoma. 1998;31:217-24.
10. Caulier M, Darloy F, Rose C. Splenic irradiation for chronic autoimmune thrombocytopenic purpura in patients with contra-indications to splenectomy. Br J Haematol. 1995:91:208-11.
11. Mozes MF, Spigos DG, Pollak R. Partial splenic embolization, an alternative to splenectomy: results of a prospective randomized study. Surgery. 1984;96:694-702.
12. Lau SK, Chu PG, Weiss LM. CD163: a specific marker of macrophages in paraffin-embedded tissue samples. Am J Clin Pathol. 2004;122:794-801.